Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong · Delayed Price · Currency is HKD 1.910
-0.085 (-4.26%)
Sep 11, 2026, 4:08 PM HKT
Clover Biopharmaceuticals Market Cap
Clover Biopharmaceuticals has a market cap or net worth of 2.48 billion as of September 11, 2026. Its market cap has increased by 1.68% in one year.
Market Cap
2.48B
Enterprise Value
2.37B
Revenue
496.42K
Ranking
n/a
PE Ratio
2.48
Stock Price
1.91
ChartMarket Cap Chart
Since November 5, 2021, Clover Biopharmaceuticals's market cap has decreased from 15.03B to 2.48B, a decrease of -83.50%. That is a compound annual growth rate of -31.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 2.48B | -18.34% |
| Dec 31, 2025 | 3.04B | 871.54% |
| Dec 31, 2024 | 312.59M | -61.08% |
| Dec 29, 2023 | 803.26M | -76.01% |
| Dec 30, 2022 | 3.35B | -78.71% |
| Dec 31, 2021 | 15.73B | 4.62% |
| Nov 5, 2021 | 15.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HJ Science | 3.02B |
| Jiangsu Recbio Technology | 3.02B |
| BioDlink International Company | 2.91B |
| Medtide | 2.82B |
| Viva Biotech Holdings | 2.74B |
| Beijing Luzhu Biotechnology | 2.71B |
| Laekna | 2.67B |
| Frontage Holdings | 2.40B |